SK Capital Expands Team with Two New Professionals Print
Business Wire
Tuesday, 03 October 2017 00:06
BackBay Communications
Zachary Tramonti, 617-391-0797
Oct. 3, 2017 10:00 UTC

SK Capital Expands Team with Two New Professionals

NEW YORK--(BUSINESS WIRE)-- SK Capital Partners, a private investment firm with a disciplined focus on the specialty materials, chemicals and pharmaceutical sectors, announced today that it has expanded its team by adding Edward Donkor as a Principal and Simon Dowker as Director of Business Development.

Prior to joining SK Capital, Mr. Donkor was a Principal at Pine Brook Partners, where he played a significant role in sourcing and executing a variety of energy investment opportunities as well as holding active board-level responsibilities for several of Pine Brook’s portfolio companies. Before joining Pine Brook, he was an investment professional at First Reserve Corporation and an investment banker in the Global Industrial and Services Group at Credit Suisse.

“We are excited to have Edward join the SK Capital team. He brings highly leverageable experience and relationships, particularly in oilfield and

related segments of the chemicals sector,” said Jack Norris, a Managing Director of SK Capital.

Simon Dowker formerly served as a Managing Director at PJT Partners focused on the global Chemicals sector. Previously, Simon worked at Jefferies where he was the Head of European Chemicals coverage. Educated as a chemical engineer, Simon started his career at UBS in London, Johannesburg and

Error. Page cannot be displayed. Please contact your service provider for more details. (12)

Dubai, where he focused on transactions in the chemicals and industrials sectors.

Aaron Davenport, a Managing Director at SK Capital, commented, “In this newly created business development role, we believe Simon’s deep industry knowledge and

relationships in our target sectors will augment our existing sourcing efforts to generate incremental opportunities in both corporate carveouts and entrepreneurial transitions.”

About SK Capital

SK Capital is a private investment firm focused on the specialty materials, chemicals and pharmaceutical sectors. SK Capital utilizes its industry, operating and investment experience to identify opportunities to transform businesses into higher performing companies with improved strategic positioning, growth, profitability and risk profiles. The firm currently has approximately $1.9 billion of assets under management and its portfolio companies generate revenues of approximately $6 billion annually and employ approximately 8,700 people.

For more information, please visit


BackBay Communications
Zachary Tramonti, 617-391-0797

Source: SK Capital Partners

BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit!! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!